Vienna, Austria

Petra Lührs

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Affiris Ag. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petra Lührs. Retrieved from https://idiyas.com/inventor/petra-lührs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Petra Lührs: Innovator in Vaccine Development

Introduction

Petra Lührs is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of vaccine development, showcasing her expertise and innovative spirit. With a focus on creating effective medical solutions, her work has the potential to impact public health positively.

Latest Patents

Petra Lührs holds one patent for a vaccine that comprises a peptide bound to a pharmaceutically acceptable carrier. This peptide features a specific amino acid sequence, highlighting her innovative approach to vaccine formulation. Her patent represents a crucial step in advancing vaccine technology.

Career Highlights

Throughout her career, Petra has demonstrated a commitment to research and development in the pharmaceutical industry. She is currently associated with Affiris AG, a company known for its pioneering work in peptide-based vaccines. Her role at Affiris AG allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Petra has worked alongside notable colleagues, including Günther Staffler and Andreas Mairhofer. Their combined expertise fosters a collaborative environment that enhances the development of innovative vaccine solutions.

Conclusion

In summary, Petra Lührs is a dedicated inventor whose work in vaccine development is paving the way for future advancements in healthcare. Her contributions, particularly through her patent and collaboration with Affiris AG, underscore her importance in the field of medical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…